Inventor · disambiguated record
Esteban Roberts
Also filed as: ROBERTS ESTEBAN
10 granted patents·3 pending applications·41 citations·filing 2012–2024
87Inventor score
Top patents by PatentIndex Score
13 records- 0195US11663717B2Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distributionVENTANA MED SYST INC·Filed 2021·Granted May 30, 2023·13 cites·13 claims
- 0288US10126216B2Method for tissue sample fixationCHAFIN DAVID·Filed 2012·Granted Nov 13, 2018·13 cites·15 claims
- 0387US11624684B2Method for tissue sample fixationVENTANA MED SYST INC·Filed 2018·Granted Apr 11, 2023·3 cites·51 claims
- 0486US9651555B2Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a markerVENTANA MED SYST INC·Filed 2013·Granted May 16, 2017·6 cites·3 claims
- 0584US10664967B2Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distributionVENTANA MED SYST INC·Filed 2017·Granted May 26, 2020·4 cites·20 claims
- 0679US12158401B2Method for tissue sample fixationVENTANA MED SYST INC·Filed 2023·Granted Dec 3, 2024·0 cites·11 claims
- 0777US11959838B2Representative diagnosticsVENTANA MED SYST INC·Filed 2018·Granted Apr 16, 2024·2 cites·43 claims
- 0876US2023184772A1Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (alk) as a markerVENTANA MED SYST INC·Filed 2022·Application pending·0 cites
- 0971US2024210288A1Representative DiagnosticsVENTANA MED SYST INC·Filed 2024·Application pending·0 cites
- 1068US11499974B2Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a markerVENTANA MED SYST INC·Filed 2020·Granted Nov 15, 2022·0 cites·11 claims
- 1165US11049247B2Methods, systems, and apparatuses for quantitative analysis of heterogeneous biomarker distributionVENTANA MED SYST INC·Filed 2020·Granted Jun 29, 2021·0 cites·20 claims
- 1262US10620207B2Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a markerVENTANA MED SYST INC·Filed 2017·Granted Apr 14, 2020·0 cites·11 claims
- 1339US2019234842A1System, method and kit for sample preparationVENTANA MED SYST INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Esteban Roberts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →